Neurocrine Biosciences income from continuous operations for the twelve months ending September 30, 2024 was $0.386B, a 102.04% increase year-over-year.
Neurocrine Biosciences annual income from continuous operations for 2023 was $0.25B, a 61.62% increase from 2022.
Neurocrine Biosciences annual income from continuous operations for 2022 was $0.155B, a 72.43% increase from 2021.
Neurocrine Biosciences annual income from continuous operations for 2021 was $0.09B, a 78% decline from 2020.
Neurocrine Biosciences Income from Continuous Operations 2010-2024 | NBIX